Here are the The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial journals presenting the latest research across various disciplines. From social sciences to technology, each article is expected to provide valuable insights to our readers.
What is the meaning of effectiveness, continuous nature of improvement, continuous glucose monitoring diabetes, effect of continuous glucose monitoring, judge the effectiveness of the presentation, continuous glucose monitoring pros and cons.
The effectiveness of continuous glucose monitoring with remote telemonitoring-enabled virtual educator visits in adults with non-insulin dependent type 2 diabetes: A randomized trial
Aims: Estimate the effectiveness of continuous glucose monitoring (CGM) with remote telemonitoring-enabled virtual diabetes educator visits for improving glycemic management in adults with type 2 diabetes, not on insulin.
Methods: Participants with type 2 diabetes, not on insulin, and HbA1c > 7.0 % were enrolled in an open-label randomized trial of 6 weeks of CGM with telemonitoring versus enhanced usual care. Both groups received educator visits. HbA1c was assessed at 12 weeks.
Results: Of 105 participants (mean age 57.3 years, 49.5 % females, mean baseline HbA1c 8.0 %), 86 remained at follow-up. Change in HbA1c was −0.69 % (CGM) versus −0.33 % (enhanced usual care). Adjusting for baseline HbA1c, CGM was superior (0.65 % greater HbA1c reduction [95 % CI 0.17–1.12 %], p = 0.008). CGM participants were 92 % (RR = 1.92, 1.19–3.06, p = 0.007) more likely to have an HbA1c reduction ≥ 0.5 %, lost more weight (difference in weight reduction 2.17 kg, 0.22–4.11, p = 0.029) and were more satisfied with their treatment. No treatment-related adverse events were observed. Conclusions: CGM with virtual diabetes educator visits is effective, safe, and acceptable in adults with type 2 diabetes not on insulin and should be considered as an alternative to drug therapy for improving blood glucose. © 2024 The Authors
Authors : Lau D.; Manca D.P.; Singh P.; Perry T.; Olu-Jordan I.; Ryan Zhang J.; Rahim G.; Hagen E.M.; Yeung R.O.
Source : Elsevier Ireland Ltd
Article Information
| Year | 2024 |
| Type | Article |
| DOI | 10.1016/j.diabres.2024.111899 |
| ISSN | 01688227 |
| Volume | 217 |
You can download the article here
If You have any problem, contact us here